Panelists discuss the evolving management of multidrug-resistant Gram-negative pathogens, highlighting current challenges, emerging therapies, clinical trial data, regulatory considerations, and strategies for integrating new treatments into clinical practice.
A panel of experts has a comprehensive discussion on Clostridioides difficile infections, focusing on characteristics of the disease, treatment practices, clinical trial data, and new fecal microbiome-based therapies.
A panel of experts discuss simplified treatment approaches for HIV, highlighting the role of the primary care and advanced practice provider, the importance of early treatment initiation, and ways to manage drug resistance.
A straight forward approach to taking care of patients with Hepatitis C. Experts in the field are offering a simplified overview for new providers on the who, what, where and when of hepatitis C care, as well as practical tips for treatment implementation
Experts discuss gut microbiota, current and emerging microbiome-based therapies for C difficile, and the practical ways to incorporate these treatments into your clinical practice.
Experts share thoughts on the flu season, the importance of testing early to differentiate between COVID-19 and influenza, and the role of clinicians and pharmacists in early testing and patient education.
A panel of infectious disease experts examines the risks and implications of multi-drug resistant HIV and discusses emerging treatment strategies that could shape clinical approaches in the future.
Expert health professionals provide key insights on recently approved SARS-CoV-2 booster shots highlighting current recommendations and optimizing patient communication and education on vaccination options.
Dr. Feuerstadt, a gastroenterologist, discusses foundational trials and ongoing studies in the use of fecal microbial transplantation (FMT) for treatment of recurrent C. difficile infections.
A panel of experts provides a thorough discussion on COVID-19 booster shots, including eligibility and safety considerations.
Expert panelists provide insight on the relationship between the gut microbiome and c difficile, leading to the development of novel therapeutic approaches for infection.
Importance of patient education and early testing to differentiate between influenza and COVID-19.
An expert multidisciplinary panel reacts to the availability of newer therapies and various strategies that may minimize adverse effects, including weight gain, from HIV treatment.
